I mentioned it earlier to you that they will be launching either approved or authorized generic Oxycontin in First Q of 2016 and last time around they made a boat load on that one!! also talk is they were speaking about Renvela when the FDA was in for inspection to finish up Hayward so the approval of that one is about to happen very soon as well. That is two monster approvals coming down the pike. These others are dressing to show the processes are working well!! ;) Later Dude!!
Who cares about that one, we know they are launching Oxycontin First Q of 2016 per CC not far back, maybe temporary as authorized. maybe approved ANDA Generic, we'll see! Then Renevela etc etc itt's coming and this one is one of the few rising of any of the generics right now. Something is coming, perhaps transformational? Courac did you buy back in near the lows recently? Later
The Bob ;) !!!! Leave rates be till middle of 2016 till rest of the world heals then move. What's it going to hurt?
Anxious hungry story hunting reporters and headline news story hunters? I mean really is this what it has come down to? It's no wonder Trump is running away with the electrion!
Like Impax has. Not sure how many were able to catch Impax near the lows the last couple of days ( Courac ;)
but if you did good job. As for the sharp in the know shorts like Gaymanyu that know more than the rest of us, well I guess we will just have to see what happens ;) None the less the moves are fast and furious and I heard a chief Investment officer from Chicago give a green light to the market for the last leg heading into the Oct- Dec Period as similar to 2011 so get ready!! Peace and good will to all!! Bob
This is a ahort term dream come true! I am loading back up and awaiting TJ to make a share buyback announcement, glad he left Atmel alone!! This company is best run and always pays its shareholders because of TJ and his ownership of shares in the company, like 9 million or so? No brainer!!
Bisaro and Saunders crafted the deal to the TEVA Boys for $40.5 Bill to the Teva boys at the right time, now it is time to step back and be selective. Seek to #$%$ to Proprietary opportunities like Rytary that Impax can offer you with their Parkinsons drug and take it global. Sit back and look selectively for other opportunities that add real zing to your bottom line. Fred Wilkensen is originally from Activis and headed the Biosim division as a President there before taking the healm as the CEO at IPXL. Keep him he is valuable and straightentened things out quickly at Impax!! Good luck!!
Take a look at IMPAX (IPXL) They can now be had for $4- $4.5 from the market pull back and they integrated a midsize pair of private generic mfgs that double next years sales. Also generic Oxyxontin launches Q1 2016 and Generic Renvela big $ maker soon after, mabe first filer! There is CBM adn a host of others that are terric buys that can be added but IPXL is a instant strategic money maker that will send shares back up!!
I Like you two and love our company and its long term prospects, this is a nugget that is just too large to digest and not worth it at this stage of the game that is what the market is saying. Gracefully step away please!!!!
There are plenty of mid size targets that offer far greater value and instant accretion to earnings and NO debt or very little!! that is the key!! Think it through please!! Thanks!!
Sinces that time the whole Generic/Biotec sector has been pummeled relentlessly!! Still believe this is the best one availabe, a far better deal than that of Par Pharma which I used to hold before they were bought private for $1.6 Bill, several years back.. I believe Impax offers more bang for the buck and is a better less expensive value!!! Check it out Rev!!
Estimates are strengenthing moving into 2016 consideribly, and being that Cypress is closely held by TJ for the right price you just never know for a well run company like this!! I'm just saying, if somone steps forward with a $20 something offer things could get very interesting as this sector has been consolidating.
Cypress is an "A" and at this level is an incredible value!!
I think you got it right U are the village idiot! What a Moron! TJ Knows more about this sector than you even know who your real father is so go back to your trailer park and stop spewing trash idiot!!
Bionic don't bother waisting a keystroke on Courac he is the definition of doubting Thomas. I walked him through hints of Hayward Redaction letter process with the FDA with hints dropped in CC from Qauterlies and he vehemently argued every point! A Long TERM SHORT OR IMPX HATER ONE OR THE OTHER FOR SURE!!!!!!!!!!!!!!!!!!!!!!!!!!!! WAIST OF BREADTH
So Generic Oxycontin will be an approved or at a mininamum an authorzaed generic where they will be an exclusive generic seller of Oxycontin ER for at least 8 months or they may be a first approved Oxycontin ER seller which is humongous! Then they are lining up and preparing for what they already were selling authorized Renvela, to be approved shortly, a huge $ maker!! and 6-8 others to follow in their newly letter lifted Harward facitlity finally since 0'11. Time to buy IPXL right after they integrated mid sized merger and launched Rytary Parkinson's 80% Proprietary drug-Profitable that needs global expertise and reach!! $4.5 billion at a $1.6 Bill discout and you get the Epipen Market head to head with the purchase!! do the research it's there!!
I think it is the next one to go any day now, worth a look as the takeovers in the generic space are read hot again!
September 03, 2015
5:53 pm ET
Bass Says Long Positions Also Include Impax Laboratories Inc., and ZS Pharma Inc.
Bass is a Billionaire Hedgefund guy that is right a lot, he does his homework and gets it right. I am a follower and believer and buyer !! I own them both and just bought more IPXL thanks to the run in ZSPH!! THANK YOU KYLE :)
Just a thought.
With the new developments and the hunger in this space this one will not last long, it is a shining value out there to many players that need what they can offer, solid long term sustained strategic growth!!!